Abbott Laboratories (ABT) Invested Capital (2009 - 2026)

Abbott Laboratories' Invested Capital history runs 18 years deep, the most recent figure standing at $86.1 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 41.88% year-over-year to $86.1 billion; the TTM figure through Mar 2026 stood at $86.1 billion (up 41.88% YoY), while the FY2025 annual figure was $65.5 billion, up 357.22% from the prior year.
• Invested Capital came in at $86.1 billion for Q1 2026 at Abbott Laboratories, up from $65.5 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $86.1 billion in Q1 2026 to a low of -$14.1 billion in Q3 2022.
• A 5-year average of $28.6 billion and a median of $15.0 billion in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital tumbled 1980.59% in 2022 and jumped 1454.56% in 2023, its largest moves.
• Abbott Laboratories' Invested Capital stood at $41.5 billion in 2022, then slumped by 64.51% to $14.7 billion in 2023, then dropped by 2.62% to $14.3 billion in 2024, then jumped by 357.22% to $65.5 billion in 2025, then jumped by 31.38% to $86.1 billion in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $86.1 billion, $65.5 billion, and $64.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison